Literature DB >> 11900665

Alterations of bcl-2, bcl-x and bax protein expressions in area CA-3 of rat hippocampus following fluid percussion brain injury.

Chun Luo1, Cheng Zhu, Jiyao Jiang, Yicheng Lu, Guangji Zhang, Guoliang Yuan, Rujue Cai, Tingjun Ye.   

Abstract

OBJECTIVE: To investigate the alterations of bcl-2 gene family in the area of CA-3 in rats and the molecular mechanism of neuronal apoptosis following traumatic brain injury.
METHODS: To investigate the alterations of bcl-2 gene family in the area of CA-3 in rats and the molecular mechanism of neuronal apoptosis following traumatic brain injury.
RESULTS: The immunoreactivity of bcl-2 and bcl-x proteins decreased in the hippocampus ipsilateral impact site at 6 hours after injury, and this was the main cause of down-regulation of the value of (bcl-2+bcl-x)/ bax. During the period of 1-3 days after injury, bax protein expression increased significantly, while bcl-2 and bcl-x protein expressions decreased relatively slowly. The decreased value of (bcl-2+bcl-x)/ bax was mainly due to the bax up-regulation.
CONCLUSIONS: The bcl-2 gene family is involved in neuronal apoptosis after traumatic brain injury, and the protein-expression alterations of the bcl-2 gene family members lead to apoptosis of the neuronal cells.

Entities:  

Year:  1999        PMID: 11900665

Source DB:  PubMed          Journal:  Chin J Traumatol        ISSN: 1008-1275


  2 in total

1.  Alantolactone plays neuroprotective roles in traumatic brain injury in rats via anti-inflammatory, anti-oxidative and anti-apoptosis pathways.

Authors:  Xun Wang; Yu-Long Lan; Jin-Shan Xing; Xiao-Qiang Lan; Li-Tao Wang; Bo Zhang
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

2.  Ginkgetin attenuates cerebral ischemia-reperfusion induced autophagy and cell death via modulation of the NF-κB/p53 signaling pathway.

Authors:  Jianqing Pan; Xiang Li; Fei Guo; Zhigang Yang; Lingling Zhang; Chunshui Yang
Journal:  Biosci Rep       Date:  2019-09-06       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.